← Back to Clinical Trials
Recruiting NCT04276922

NCT04276922 Creative Arts Program to Reduce Burnout in Healthcare Professionals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04276922
Status Recruiting
Phase
Sponsor University of Colorado, Denver
Condition Burn-Out Syndrome
Study Type INTERVENTIONAL
Enrollment 195 participants
Start Date 2020-03-01
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Visual ArtsMusicDance/Movement

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 195 participants in total. It began in 2020-03-01 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study plans to learn if creative arts programs that include visual, musical, written, or physical expression can reduce symptoms of burnout syndrome, Post Traumatic Stress Disorder (PTSD), depression, and anxiety in critical care healthcare professionals. This study also explores if creative arts can enhance the connection to the purpose of work, the development of adequate coping skills, while providing time to connect with peers.

Eligibility Criteria

Inclusion Criteria: * Employed as a healthcare provider, practicing primarily in a hospital setting for at least 20 hours per week. * Positive symptoms of burnout measured via the Maslach Burnout Inventory (MBI): * emotional exhaustion score of \>17, or * depersonalization score of \>7, or * personal accomplishment score of \< 31. Exclusion Criteria: • Unwillingness to participate in any of the four creative arts interventions.

Contact & Investigator

Central Contact

Rafaela Mantelli, BS

✉ rafaela.mantelli@cuanschutz.edu

📞 303-724-6377

Principal Investigator

Marc Moss, MD

PRINCIPAL INVESTIGATOR

University of Colorado, Denver

Frequently Asked Questions

Who can join the NCT04276922 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Burn-Out Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04276922 currently recruiting?

Yes, NCT04276922 is actively recruiting participants. Contact the research team at rafaela.mantelli@cuanschutz.edu for enrollment information.

Where is the NCT04276922 trial being conducted?

This trial is being conducted at Aurora, United States.

Who is sponsoring the NCT04276922 clinical trial?

NCT04276922 is sponsored by University of Colorado, Denver. The principal investigator is Marc Moss, MD at University of Colorado, Denver. The trial plans to enroll 195 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology